• Do GLP-1s Change the Meaning of "Obesity"?

  • Oct 1 2024
  • Length: 44 mins
  • Podcast

Do GLP-1s Change the Meaning of "Obesity"?

Listen for free

View show details

  • Summary

  • With the advent of GLP-1 drugs, it was only a matter of time before Brad and Gabriel dove into a discussion about this controversial drug class and the equally contentious disease, obesity. In this episode, they explore a range of topics—from the history of obesity and its recognition as a disease to how GLP-1s like Ozempic are influencing the conversation around the legitimacy and stigma of obesity beyond just Body Mass Index (BMI).

    One of the most compelling ideas from this thought-provoking episode centers on control—how we perceive our own health and judge others, assuming people have more control over their health outcomes than they really do. This theme cuts to the heart of the obesity debate: are we excusing unhealthy habits, or are we acknowledging that the issue is far more complex than we originally thought?

    The inspiration for this episode: https://www.nytimes.com/2024/09/19/opinion/obesity-disease-ozempic-weight-loss.html


    If you have any questions, feedback, or just want to say hi, email us at medicalanthropology@havas.com

    Check out Breaking the Code on LinkedIn: https://www.linkedin.com/company/breaking-the-code-havas-health-and-you-podcast
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Do GLP-1s Change the Meaning of "Obesity"?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available